ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Schrodinger Inc

Schrodinger Inc (SDGR)

25.075
-0.355
(-1.40%)
Closed February 02 3:00PM
25.0005
-0.0745
(-0.30%)
After Hours: 6:57PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

SDGR News

Official News Only

SDGR Discussion

View Posts
jsc52033 jsc52033 2 months ago
If Biill Gates thinks its got potential it a risk I can take
πŸ‘οΈ0
lambchops lambchops 3 months ago
Yep, it just seems like SDGR isn't getting much love. But nothing has changed as they move towards their goals. I look at it as aa time to continue to accumulate shares. One of these days SDGR will see a big jump.

Look at CERS.

All the best! stay in contact.

LC

SDGR
πŸ‘οΈ0
north40000 north40000 3 months ago
Not much to say, currently. SDGR shares have been in a rather steady decline since I purchased a few in May 2023. I am curious where/how the company is aiding discovery of new molecules for potential use in healthcare sector, cf. the recent Nobel Prize awards. Is this turnaround time? How proficient has the company been in its AI-aided experiments?

I have concentrated more on NVDA, IONQ, JNJ, PFE, MRK, GILD, HALO, CPRX, VCEL, WGS whose market valuations seem headed higher in our portfolios.
πŸ‘οΈ0
lambchops lambchops 7 months ago
Anybody interested on posting on this one?

LC

πŸ‘οΈ0
scotsand scotsand 1 year ago
This needs to turn around soon. So oversold.
πŸ‘οΈ0
scotsand scotsand 2 years ago
Beast mode
πŸ‘οΈ0
scotsand scotsand 2 years ago
Love this ticker
πŸ‘οΈ0
scotsand scotsand 2 years ago
Up 20%. Guess was right… adding.
πŸ‘οΈ0
scotsand scotsand 2 years ago
Now is the time to add.
πŸ‘οΈ0
Porterhouse10 Porterhouse10 3 years ago
Cathy Woods adding
πŸ‘οΈ0
nowwhat2 nowwhat2 3 years ago



πŸ‘οΈ0
adtime adtime 3 years ago
This was a fun move hope someone followed ;) 8% at peak today ftw
πŸ‘οΈ0
adtime adtime 3 years ago
Nice set up if gets into 60
πŸ‘οΈ0
ernie44 ernie44 4 years ago
M and A -------------------------
merger looming---microsoft
πŸ‘οΈ0
Bucketh3ad Bucketh3ad 5 years ago
Smh
πŸ‘οΈ0
chrispy2468 chrispy2468 5 years ago
Any insight to this upward move after hours?
πŸ‘οΈ0
canadiansalmongal canadiansalmongal 5 years ago
Very Solid company with HUGE money supporting it...Long term Hold this is a golden ticket going forward $100 PT this time next year!
πŸ‘οΈ0
chrispy2468 chrispy2468 5 years ago
Little action AH
πŸ‘οΈ0
RodgeDodger RodgeDodger 5 years ago
Still running
πŸ‘οΈ0
crudeoil24 crudeoil24 5 years ago
I am not holding shares. It may run some more, plus not everyone is familiar with Citron the beast! > LOL.
πŸ‘οΈ0
realfast95 realfast95 5 years ago
yea he exaggerates his long ideas. TLRY,RVLV come to mind
πŸ‘οΈ0
crudeoil24 crudeoil24 5 years ago
Citron > will they be shorting tomorrow? Playing off the TSLA hype!

πŸ‘οΈ0
chrispy2468 chrispy2468 5 years ago
Bullish
πŸ‘οΈ0
TheFinalCD TheFinalCD 5 years ago
https://citronresearch.com/schrodinger-sdgr-taking-drug-discovery-to-the-space-age/
πŸ‘οΈ0
realfast95 realfast95 5 years ago
Citron pump

https://twitter.com/CitronResearch/status/1230538195726503942

Citron Research
@CitronResearch
$SDGR the most important IPO past 5 years. Taking drug discovery to "space age". The parallels to an early stage $TSLA are too obvious to ignore. Don't take Citron's word, look at the majority shareholders AI molecular simulation is real disruption. TGT- $80

πŸ‘οΈ0
RodgeDodger RodgeDodger 5 years ago
Still running
πŸ‘οΈ0
crudeoil24 crudeoil24 5 years ago
Schrodinger Shares Surge 55% After IPO Priced Above High End of Range >SDGR
12:39 pm ET February 6, 2020 (Dow Jones) Print
By Colin Kellaher

Shares of Schrodinger Inc. (SDGR) jumped more than 55% in their trading debut Thursday after the drug discovery software company's upsized initial public offering of 11.9 million shares was priced at $17 apiece, above the expected range.

Schrodinger shares recently were trading at $26.54, up about 56%, after opening at $26.

The New York company, whose investors include D.E. Shaw and the Bill & Melinda Gates Foundation, previously said it planned to sell 10 million shares at $14 to $16 each in the IPO.

The company has granted the underwriters an option to buy up to 1.78 million additional shares.
πŸ‘οΈ0
crudeoil24 crudeoil24 5 years ago
Schrodinger Inc is headquartered in New York City, New York, United States and is a software publisher. The company's key areas of interest are Computational Chemistry Software, Molecular Modeling, Dockings, Homology Modeling, Cheminformatics, Pharmacophore Modeling, Qsars, Computational Biology, Computer Chemistry, Quantum Chemistry, Software For Chemistry. The company was founded in 1995.

πŸ‘οΈ0